Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Mitochondrial medicine for internists].

U A Walker1

  • 1Abteilung Rheumatologie und Klinische Immunologie, Medizinische Universitätsklinik, Freiburg. walkerul@uni-freiburg.de

Medizinische Klinik (Munich, Germany : 1983)
|February 24, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Increased radiographic progression of distal hand osteoarthritis occurring during biologic DMARD monotherapy for concomitant rheumatoid arthritis.

Arthritis research & therapy·2021
Same author

Long-term immunogenicity after yellow fever vaccination in immunosuppressed and healthy individuals.

Vaccine·2020
Same author

Use of vasoactive/vasodilating drugs for systemic sclerosis (SSc)-related digital ulcers (DUs) in expert tertiary centres: results from the analysis of the observational real-life DeSScipher study.

Clinical rheumatology·2019
Same author

Classification, categorization and essential items for digital ulcer evaluation in systemic sclerosis: a DeSScipher/European Scleroderma Trials and Research group (EUSTAR) survey.

Arthritis research & therapy·2019
Same author

There is a need for new systemic sclerosis subset criteria. A content analytic approach.

Scandinavian journal of rheumatology·2017
Same author

The ultrasound compression sign to diagnose temporal giant cell arteritis shows an excellent interobserver agreement.

Clinical and experimental rheumatology·2015
Same journal

Medizinische Klinik (Munich, Germany : 1983)·2020
Same journal

Medizinische Klinik (Munich, Germany : 1983)·2020
Same journal

Medizinische Klinik (Munich, Germany : 1983)·2020
Same journal

[Not Available].

Medizinische Klinik (Munich, Germany : 1983)·2016
Same journal

[Not Available].

Medizinische Klinik (Munich, Germany : 1983)·2016
Same journal

[Not Available].

Medizinische Klinik (Munich, Germany : 1983)·2014
See all related articles

Human mitochondrial DNA (mtDNA) mutations cause various diseases and drug side effects. Understanding these genetic changes is crucial for diagnosing and treating mitochondrial disorders.

Area of Science:

  • Genetics
  • Molecular Biology
  • Human Physiology

Context:

  • Human mitochondrial DNA (mtDNA) encodes essential proteins for cellular respiration.
  • mtDNA mutations, deletions, and copy-number variations are linked to human diseases.
  • While typically maternally inherited, mtDNA alterations can also arise spontaneously or via nuclear DNA defects.

Purpose:

  • To review the role of mitochondrial DNA (mtDNA) in human health and disease.
  • To highlight the diverse clinical manifestations of mtDNA-related disorders.
  • To discuss the impact of acquired mtDNA alterations on drug toxicity.

Summary:

  • mtDNA mutations are implicated in myopathies, cardiomyopathies, lactic acidosis, diabetes, and neurological, hematologic, and renal conditions.

Related Experiment Videos

  • Acquired mtDNA alterations contribute to adverse drug reactions from treatments like ifosfamide, carboplatin, doxorubicin, and nucleoside analogs.
  • Specific mtDNA mutations confer susceptibility to drug-induced hearing loss, such as with aminoglycosides.

    • Impact:

    • Provides a comprehensive overview of mtDNA's role in inherited and acquired human diseases.
    • Emphasizes the clinical relevance of mtDNA analysis for internists and pharmacologists.
    • Highlights the genetic basis of mitochondrial disorders and drug toxicities for improved patient care.